Pharmacodynamics of Plasma Nitrate/Nitrite as an Indication of Nitric Oxide Formation in Conscious Dogs
- 15 June 1995
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 91 (12) , 2982-2988
- https://doi.org/10.1161/01.cir.91.12.2982
Abstract
Background The present investigation was undertaken to better understand the production of nitric oxide (NO) in vivo as measured by alterations in plasma nitrite or nitrate in blood samples from studies in experimental animals or clinical studies in humans. Methods and Results Plasma samples were taken from the aorta, the coronary sinus, a peripheral vein in the leg (skeletal muscle), or the right ventricle (mixed venous) in chronically instrumented conscious dogs. Plasma nitrite was converted to NO gas in an argon environment by use of hydrochloric acid, and plasma nitrate was converted first to nitrite with nitrate reductase and then to NO gas with acid. Standard curves were constructed, and the amount of nitrite and nitrate in plasma was determined. The primary metabolite was nitrate, whereas nitrite was approximately 10% of the total and remained constant. In the resting dog, the only vascular bed with a positive arterial-venous nitrate difference, evidence for production of NO, was the heart. Nitrate infusion into quietly resting dogs resulted in increases in plasma nitrate up to 38±3.4 mmol/L, increases in systemic arterial pressure, and a marked diuresis. The plasma half-life was calculated as 3.8 hours. The volume of distribution was calculated as 0.215 L/kg, or equivalent to the extracellular volume. Conclusions These studies indicate that nitrate is a reliable measure of NO metabolism in vivo but that because of the long half-life, nitrate will accumulate in plasma once it is produced. Because of the large volume of distribution (21% of body weight versus the 4% of body weight usually attributed to plasma volume, the compartment in which nitrate is measured), simple measures of plasma nitrate underestimate by a factor of 4 to 6 the actual production of nitrate or NO by the body. In disease states, such as heart failure, in which renal function and extracellular volume are altered, caution should be exercised when increases in nitrate in plasma as an index of NO formation are evaluated.Keywords
This publication has 19 references indexed in Scilit:
- Nitric oxide synthase activities in human myocardiumThe Lancet, 1993
- The 1991 Ulf von Euler Lecture:Thel‐arginine: nitric oxide pathwayActa Physiologica Scandinavica, 1992
- Systemic vasoconstriction induced by inhibition of nitric oxide synthesis is attenuated in conscious dogs with heart failureCardiovascular Research, 1991
- Quantitation of nitric oxide formation from nitrovasodilator drugs by chemiluminescence analysis of headspace gasJournal of Pharmacological Methods, 1991
- Pharmacokinetic Aspects of Inorganic Nitrate Ingestion in ManBasic & Clinical Pharmacology & Toxicology, 1991
- Nitric oxide formed by nitrite reductase of Paracoccus denitrificans is sufficiently stable to inhibit cytochrome oxidase activity and is reduced by its reductase under aerobic conditionsBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1990
- Biosynthesis and Metabolism of Endothelium-Derived Nitric OxideAnnual Review of Pharmacology and Toxicology, 1990
- Endothelium and control of vascular function. State of the Art lecture.Hypertension, 1989
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980
- Concentrations of nitrate in normal human urine and the effect of nitrate ingestionToxicology and Applied Pharmacology, 1978